SARTORIUS AG UNSP.ADR 1/5 (SRT4) - Total Liabilities
Based on the latest financial reports, SARTORIUS AG UNSP.ADR 1/5 (SRT4) has total liabilities worth €5.98 Billion EUR (≈ $6.99 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check SARTORIUS AG UNSP.ADR 1/5 liquidity resilience to evaluate the company's liquid asset resilience ratio.
SARTORIUS AG UNSP.ADR 1/5 - Total Liabilities Trend (2021–2025)
This chart illustrates how SARTORIUS AG UNSP.ADR 1/5's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see how large is SARTORIUS AG UNSP.ADR 1/5's balance sheet.
SARTORIUS AG UNSP.ADR 1/5 Competitors by Total Liabilities
The table below lists competitors of SARTORIUS AG UNSP.ADR 1/5 ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Cipher Mining Inc
NASDAQ:CIFR
|
USA | $6.91 Billion |
|
NexGen Energy Ltd.
TO:NXE
|
Canada | CA$767.98 Million |
|
Flughafen Zurich
SW:FHZN
|
Switzerland | CHF2.42 Billion |
|
Nemetschek AG O.N.
XETRA:NEM
|
Germany | €1.36 Billion |
|
Maase Inc.
NASDAQ:MAAS
|
USA | $61.15 Million |
|
KakaoBank Corp
KO:323410
|
Korea | ₩71.04 Trillion |
|
Shanghai Allist Pharmaceuticals Co. Ltd. A
SHG:688578
|
China | CN¥842.81 Million |
|
ALPHA SE+H.ADR1/4/EO 390
F:ACBC
|
Germany | €68.63 Billion |
Liability Composition Analysis (2021–2025)
This chart breaks down SARTORIUS AG UNSP.ADR 1/5's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See SARTORIUS AG UNSP.ADR 1/5 (SRT4) net asset quality to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.91 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.19 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.61 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how SARTORIUS AG UNSP.ADR 1/5's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for SARTORIUS AG UNSP.ADR 1/5 (2021–2025)
The table below shows the annual total liabilities of SARTORIUS AG UNSP.ADR 1/5 from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €5.85 Billion ≈ $6.84 Billion |
-5.73% |
| 2024-12-31 | €6.21 Billion ≈ $7.25 Billion |
-11.20% |
| 2023-12-31 | €6.99 Billion ≈ $8.17 Billion |
+61.79% |
| 2022-12-31 | €4.32 Billion ≈ $5.05 Billion |
+8.58% |
| 2021-12-31 | €3.98 Billion ≈ $4.65 Billion |
-- |
About SARTORIUS AG UNSP.ADR 1/5
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors; software apps for bioreactors and cell culture shake flasks; fermenters; cell culture media, biolayer interferometry, microbiological testing, and fluid management pro… Read more